20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T60029 | SOS1-IN-11 | Raf | |
SOS1-IN-11 is an effective inhibitor of SOS1 (IC50 = 30 nM). | |||
T73164 | SOS1-IN-15 | Raf | |
SOS1-IN-15 is an orally active and potent SOS1 inhibitor with potential antitumor activity.SOS1-IN-15 is used in the study of colon cancer. | |||
T12978 | NSC-70220 | SOS1-IN-1 | Raf |
SOS1-IN-1 is an inhibitor of SOS1. | |||
T63118 | SOS1-IN-8 | ||
SOS1-IN-8 is an inhibitor of SOS1 and acts on SOS1-G12D (IC50: 11.6 nM) and SOS1-G12V (IC50: 40.7 nM). | |||
T62712 | SOS1-IN-10 | ||
SOS1-IN-10 is a potent inhibitor of SOS1 that acts on KRAS G12C-SOS1 (IC50: 13 nM). | |||
T61963 | SOS1-IN-3 | ||
SOS1-IN-3 is an effective inhibitor of SOS1 (son of sevenless homolog 1) (IC50=5 nM). SOS1-IN-3 shows antitumor activity. | |||
T79183 | SOS1-IN-16 | Ras | |
SOS1-IN-16 (Comp 54) serves as a selective SOS1 inhibitor exhibiting an IC50 value of 7.2 nM and demonstrates inhibitory activity against CYP3A4 with an IC50 of 8.9μM when testosterone is employed as a substrate. This co... | |||
T63044 | SOS1-IN-6 | ||
SOS1-IN-6 (compound 33-P1) is a potent inhibitor of SOS1, acting on SOS1-G12D (IC50: 14.9 nM) and SOS1-G12V (IC50: 73.3 nM). | |||
T62003 | SOS1-IN-13 | ||
SOS1-IN-13 is a potent inhibitor of son of sevenless homolog 1 (SOS1). SOS1-IN-13 shows IC 50 s of 6.5 nM and 327 nM for SOS1 and pERK, respectively. SOS1-IN-13 has research value in anticancer. | |||
T63083 | SOS1-IN-4 | ||
SOS1-IN-4 is a potent inhibitor of SOS1 (IC50: 56 nM) and can be used in the study of KRAS-C12C/SOS1 interactions. | |||
T63781 | SOS1-IN-5 | ||
SOS1-IN-5 is a pyrimidine bicyclic derivative and a potent inhibitor of SOS1. SOS1-IN-5 interferes with the RAS-SOS1 interaction, thereby blocking KRAS activation and exhibiting broad-spectrum inhibition of KRAS activity... | |||
T62923 | SOS1-IN-7 | ||
SOS1-IN-7 (compound 18-p1) is a potent inhibitor of SOS1 and acts on SOS1-G12D (IC50: 20 nM) and SOS1-G12V (IC50: 67 nM). | |||
T62478 | SOS1-IN-9 | ||
SOS1-IN-9 is a potent inhibitor of SOS1 that acts on KRAS G12C-SOS1 (IC50: 116.5 nM). | |||
T62371 | SOS1-IN-12 | ||
SOS1-IN-12 is a potent inhibitor of SOS1, acting on SOS1 (Ki: 0.11 nM) and on pERK (IC50: 47 nM). | |||
T63887 | SOS1-IN-14 | ||
SOS1-IN-14 is a selective, potent, orally active SOS1 inhibitor (IC50: 3.9 nM). sOS1-IN-14 is absorbed in the intestine using a P-glycoprotein-mediated efflux mechanism. sOS1-IN-14 can be used in the study of KRAS mutate... | |||
T63201 | SOS1 activator 1 | ||
SOS1 activator 1 is an activator of SOS1-mediated nucleotide exchange (Kd: 44 nM).SOS1 is a guanine nucleotide exchange factor that binds to Ras proteins and catalyzes the exchange of GDP for GTP on RAS, resulting in the... | |||
T79162 | SOS1/KRAS-IN-1 | Ras | |
SOS1/KRAS-IN-1 (Compound 2) serves as an inhibitor of SOS1/KRAS, with potential application in the study of diseases mediated by SOS1/KRAS [1]. | |||
T79098 | PROTAC SOS1 degrader-4 | PROTACs | |
PROTAC SOS1 Degrader-4 (compound 10) is a potent degrader of SOS1 and exhibits antiproliferative activity [1]. | |||
T75020 | PROTAC SOS1 degrader-3 | ||
PROTAC SOS1 Degrader-3 is a potent agent specifically designed to target and degrade SOS1 via the ubiquitin-proteasome system [1]. | |||
T74356 | PROTAC SOS1 degrader-2 | ||
PROTAC SOS1 degrader-2, a potent degrader of PROTAC SOS1, effectively reduces the expression of pERK and RAS-GTP in a dose-dependent manner. It significantly inhibits tumor growth in vivo [1]. |